Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EMD-1214063 displays potent and selective c-Met inhibition

April 27, 2010

Pfizer halts phase III trial of Sutent in liver cancer

April 26, 2010

Aragon secures financing to advance ARN-509

April 26, 2010

Genentech submits supplemental BLA to FDA for Herceptin in stomach cancer

April 26, 2010

Celtic Pharma evaluates Xerecept in pediatric patients with metastatic brain tumors

April 26, 2010

XL-647/sorafenib combination shows promise in preclinical models of HCC

April 26, 2010

Boehringer Ingelheim identifies new B-raf inhibitors

April 26, 2010

Delcath reports phase III data on Delcath PHP System-delivered melphalan

April 23, 2010

Genmab begins new next-generation antibody program HuMax-cMet

April 23, 2010

Nerviano Medical Sciences discovers new B-raf inhibitors for cancer therapy

April 23, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...